Self-testing for HIV and its impact on public health

Sexually Transmitted Diseases

Volumn 41, Issue 1, 2014, Pages 10-12

  Hurt, Christopher B ^a   Powers, Kimberly A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COUNSELING; DRIED BLOOD SPOT TESTING; EDITORIAL; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; LABORATORY; PUBLIC HEALTH; RAPID TEST; RISK; SELF CONCEPT; SELF EVALUATION; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE;

FEMALE; HIV INFECTIONS; HUMANS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PUBLIC HEALTH; SELF CARE; SOCIAL STIGMA; UNITED STATES;

EID: 84891587173     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000076     Document Type: Editorial

References (28)

1. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance dataVUnited States and 6 U.S. dependent areasV2010. HIV Surveillance Supplemental Report. Vol 17 (No. 3, Part A). Atlanta, GA; 2012.
2. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011; 52(6):793-800.
3. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 2012;26(7):893-896.
4. White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. Washington, DC; 2010. Available at: http://aids.gov/ federal-resources/national-hiv-aids-strategy/nhas.pdf. Accessed October 7, 2013.
5. Frerichs RR. Personal screening for HIV in developing countries. Lancet 1994;343(8903):960-962.
6. Bayer R, Stryker J, Smith MD. Testing for HIV infection at home. N Engl J Med 1995;332(19):1296-1299.
7. Branson BM. Home sample collection tests for HIV infection. JAMA 1998;280(19):1699-1701.
8. Colfax GN, Lehman JS, Bindman AB, et al. What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infection. AIDS Care 2002;14(5):675-682.
9. Greensides DR, Berkelman R, Lansky A, et al. Alternative HIV testing methods among populations at high risk for HIV infection. Public Health Rep 2003;118(6):531-539.
10. Food and Drug Administration. Approval Letter-OraQuick Rapid HIV-1 Antibody Test. November 7, 2002; http://www.fda.gov/BiologicsBloodVaccines/ BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/ucm091994.htm. AccessedOctober 11, 2013.
11. Food and Drug Administration. CLIA waiver granted to OraQuick ADVANCE Rapid HIV-1/2 Antibody Test. 2004. Available at: http://www.fda.gov/ ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm125023.htm. Accessed October 11, 2013.
12. Spielberg F, Levine RO, Weaver M. Self-testing for HIV: A new option for HIV prevention? Lancet Infect Dis 2004;4(10):640-646.
13. Walensky RP, Paltiel AD. Rapid HIV testing at home: does it solve a problem or create one? Ann Intern Med 2006;145(6):459-462.
14. Ventuneac A, Carballo-Dieguez A, Leu CS, et al. Use of a rapid HIV home test to screen sexual partners: An evaluation of its possible use and relative risk. AIDS Behav 2009;13(4):731-737.
15. Food and Drug Administration. FDA approves first over-thecounter home-use rapid HIV test. 2012; Available at: http://www. fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm310542.htm Accessed August 25, 2012.
16. OraSure Technologies. Final Advisory Committee Briefing Materials: Available for Public Release. OraQuick\ In-Home HIV Test. Bethlehem, PA.: Blood Products Advisory Committee, U.S. Food and Drug Administration; 2012.
17. Stekler J, Wood RW, Swenson PD, et al. Negative rapid HIV antibody testing during early HIV infection. Ann Intern Med 2007; 147:147-148.
18. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a highincidence population: Is antibody testing alone good enough? Clin Infect Dis 2009;49:444-453.
19. Pilcher CD, Tien HC, Eron JJ Jr, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004;189:1785-1792.
20. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007;195:951-959.
21. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: A modelling study. Lancet 2011;378:256-268.
22. Xiridou M, Geskus R, de Wit J, et al. Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS 2004;18:1311-1320.
23. Katz DA, Cassels SL, Stekler JD. Replacing clinic-based tests with home-use tests may increase HIV prevalence among Seattle men who have sex with men: Evidence from a mathematical model. Sex Transm Dis 2013;41:2-9.
24. Blood Products Advisory Committee. Issue Summary: Safety and Effectiveness of the Proposed OraQuick\ In-Home HIV Test. Washington, DC: Food and Drug Administration; 2012.
25. Masciotra S, McDougal JS, Feldman J, et al. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011;52(suppl 1):S17-22.
26. Owen SM, Yang C, Spira T, et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008;46:1588-1595.
27. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
28. Muessig KE, Smith MK, Powers KA, et al. Does ART prevent HIV transmission among MSM? AIDS 2012;26:2267-2273.